Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anemia, Refractory, with Excess of Blasts × Methotrexate × 90 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 21 Burkitt Lymphoma 15 Leukemia, Biphenotypic, Acute 9 Leukemia, Myeloid, Acute 8 Myelodysplastic Syndromes 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Medulloblastoma 4 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3 Osteosarcoma 3 Neoplasm Metastasis 3 Lymphoma 3 Leukemia 3 Urinary Bladder Neoplasms 2 Recurrence 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Leukemia, Myelomonocytic, Juvenile 2 Leukemia, Myeloid, Accelerated Phase 2 Graft vs Host Disease 2 Blast Crisis 2 Squamous Cell Carcinoma of Head and Neck 1 Shwachman-Diamond Syndrome 1 Sarcoma, Ewing 1 Rhabdoid Tumor 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Primary Myelofibrosis 1 Philadelphia Chromosome 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1

Interventions

Cyclophosphamide 6 fludarabine 5 Mycophenolic Acid 5 Azacitidine 5 Whole-Body Irradiation 4 Tacrolimus 4 venetoclax 3 fludarabine phosphate 3 decitabine and cedazuridine drug combination 2 Vorinostat 2 Specimen Handling 2 Melphalan 2 Granulocyte Colony-Stimulating Factor 2 Busulfan 2 Biopsy 2 sulforaphane 1 ruxolitinib 1 enasidenib 1 cedazuridine 1 Triamcinolone 1 TAK-243 1 Stem Cell Transplantation 1 Sirolimus 1 Peripheral Blood Stem Cell Transplantation 1 Mesna 1 Lenalidomide 1 Hematopoietic Stem Cell Transplantation 1 Filgrastim 1 Cyclosporins 1 Cyclosporine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡